Rapport Therapeutics, Inc. - RAPP
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G/A | Cormorant Asset Management, LP | 6.35% | 3,027,521 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Bihua Chen | 6.35% | 3,027,521 | View |
| Jan 21, 2026 | SCHEDULE 13G | BlackRock, Inc. | 5.03% | 2,397,549 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Cormorant Asset Management, LP | 6.7% | 3,192,521 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Bihua Chen | 6.7% | 3,192,521 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.